Astellas and Kyowa Kirin Agree on MFN Pricing with the U.S. Government; Leqembi Recommended for Public Reimbursement in Canada, and More | Pharmaceutical Industry News Roundup for 1 September 2026 | News
Astellas and Kyowa Kirin Agree on MFN Pricing with the U.S. Government; Leqembi Recommended for Public Reimbursement in Canada, and More | Pharmaceutical Industry News Roundup for 1 September 2026
Read in fullFrom the source, not the headline
1
sources corroborateOutlets reporting the same event
0
companies linkedAcross 0 themes, second pass
The story
No summary is published for this storyThe automatic check found assertive wording, so the summary is withheld. The sources and linked themes are still shown.
Where this came from
We read each source in full and checked they agree on the core claim.